brentuximab vedotin April 12, 2017 brentuximab vedotin Trade Name Orphan Indication Adult T-cell leukemia/lymphoma USA Market Approval USA USA Designation Date 2016-05-23 00:00:00 Sponsor Seattle Genetics, Inc.;21823 30th Drive Southeast;Bothell, Washington, 98021
